Results 11 to 20 of about 7,852 (177)

Efficacy and Safety of Combined Autologous Blood and Minocycline Pleurodesis for Intractable Pneumothorax in High-Risk Non-Surgical Patients: A Case Series. [PDF]

open access: yesRespirol Case Rep
This case series suggests that sequential, non‐mixed autologous blood plus minocycline pleurodesis is a feasible option for intractable secondary spontaneous pneumothorax (SSP) in high‐risk, nonsurgical patients, many of whom had ILD and/or severe COPD.
Koh E, Sekine Y.
europepmc   +2 more sources

Successful Combined Autologous Blood and Minocycline Pleurodesis for Intractable Bilateral Pneumothorax in an Elderly Patient With Combined Pulmonary Fibrosis and Emphysema: A Case Report. [PDF]

open access: yesRespirol Case Rep
We describe reproducible, complication‐free control of bilateral pneumothoraces in an octogenarian with CPFE using combined autologous blood and minocycline pleurodesis. ABSTRACT Bilateral pneumothorax in elderly patients with combined pulmonary fibrosis and emphysema (CPFE) is rare and often precludes surgery.
Koh E.
europepmc   +2 more sources

Synergistic Sealing of the Pleural Space: Combining Thoracoscopic Talc Poudrage and IPC for Malignant Pleural Effusion-A Case Series. [PDF]

open access: yesRespirol Case Rep
We describe the technique of performing talc poudrage and indwelling pleural catheter (IPC) insertion during the same setting to enhance procedural efficiency and patient outcomes. We report a case series of malignant pleural effusion demonstrating successful pleurodesis within 2–4 weeks using this combined approach.
Mohamad Jailaini MF   +3 more
europepmc   +2 more sources

Persistent Low-Output Neonatal Chylothorax: How Long Are We Justified to Wait for Pleurodesis in Partial Responders? [PDF]

open access: yesPediatr Pulmonol
ABSTRACT Aims The aim of our study was to review our experience regarding the management of neonatal chylothorax, with particular focus on outcomes of partial responders. Methods We conducted a retrospective analysis of neonatal chylothorax cases between January 2015 and December 2023.
Rollo G   +9 more
europepmc   +2 more sources

Intrapleural Administration of Hypotonic Cisplatin for Patients With Malignant Pleural Effusions and Non-Expandable Lungs. [PDF]

open access: yesThorac Cancer
Intrapleural administration of hypotonic cisplatin (HPT) decreased or stabilized pleural effusions and was well tolerated in patients with malignant pleural effusion and non‐expandable lungs. ABSTRACT Background/Objectives Thoracostomy and pleurodesis are the mainstay of management for malignant pleural effusions (MPEs). However, pleurodesis may not be
Mori W   +9 more
europepmc   +2 more sources

Sonographic evaluation of different sclerosing agents in pleurodesis of malignant pleural effusion at Zagazig University Hospitals

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2018
Background Malignant pleural effusion (MPE) arises in advanced stages of malignancies and frequently carries a poor prognosis. The most common management of the patients with refractory MPE is pleurodesis.
Mohammed M.N AboZaid   +2 more
doaj   +1 more source

Evaluation of pleurodesis by poly-ε-caprolactone (PCL) gel in an animal model using New Zealand white rabbits

open access: yesAsian Journal of Surgery, 2019
Summary: Background/Purpose: Pleurodesis with biomaterial implant is an emerging treatment method for pleural diseases. However, the ideal biomaterial or the optimal form for the common diseases is still under investigation.
Cheng-Hung How   +5 more
doaj   +1 more source

Pleurabrade: A Spiral Brush for Mechanical Pleurodesis and a Review of the Literature

open access: yesThe Thoracic & Cardiovascular Surgeon Reports, 2021
Background While the optimal treatment for primary spontaneous pneumothorax remains unclear, mechanical pleurodesis is a well-established treatment. The Pleurabrade is a spiral brush designed for mechanical pleurodesis during thoracoscopy. We present two
John S. Young   +3 more
doaj   +1 more source

The impact of repeated thoracentesis on the outcome of chemical pleurodesis in malignant pleural effusion

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2012
Repeated thoracentesis may cause pleural inflammation and induce local release of proinfammatory cytokine as tumor necrosis factor-α (TNF-α) which may subsequently enhance the release of plasminogen activator inhibitor-1 (PAI-1) and lead to fibrin ...
Adel Salah   +3 more
doaj   +1 more source

Assessment of diaphragmatic mobility by chest ultrasound and basic echocardiography in patients with malignant pleural effusion undergoing pleurodesis

open access: yesEgyptian Journal of Chest Disease and Tuberculosis, 2022
Background Malignant pleural effusion (MPE) is prevalent, and in cases such as aging patients as well as increased long-term survival for metastatic cancers, the number of patients will continue to elevate in the near future.
Adel M Saeed   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy